-->

Tag: Dostarlimab FDA approval

Home / Dostarlimab FDA approval

Categories

The FDA has broadened the indication for dostarlimab-gxly to include the treatment of endometrial cancer in combination with chemotherapy

August 2024: The Food and Drug Administration has granted approval for dostarlimab-gxly (Jemperli, GSK) in combination with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for t...
dostarlimab-fda-approval

Dostarlimab-gxly with chemotherapy is approved by the FDA for endometrial cancer

August 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), followed by dostarlimab-gxly as a single agent, was approved by the Food and Drug Administration for the treatment of primary advanced or re...
dostarlimab-fda-approval

Scan the code